Trials / Terminated
TerminatedNCT02260141
Treating Alzheimer's and Dementia With D-ribose
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Practitioners Alliance Network · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
Detailed description
Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks to monitor outcomes in a pilot study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | d-ribose | giving ribose in those with a diagnosis of Alzheimer's and/or dementia |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2014-10-09
- Last updated
- 2020-05-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02260141. Inclusion in this directory is not an endorsement.